PD-1 Innovation: How TEVIMBRA Is Reshaping Immuno-Oncology Treatment Option...

In a significant development for cancer patients worldwide, BeiGene's TEVIMBRA (tislelizumab) has secured an important new indication, reinforcing its position...

• davidcracc